These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 271046)
1. Time relationship between last dose of daunorubicin and congestive heart failure. Von Hoff DD; Layard M; Rozencweig M; Muggia FM Cancer Treat Rep; 1977 Oct; 61(7):1411-3. PubMed ID: 271046 [No Abstract] [Full Text] [Related]
2. A phase 1 and 2 trial of rubidazone in patients with acute leukemia. Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389 [No Abstract] [Full Text] [Related]
3. Cardiac ultrastructural changes induced by daunorubicin therapy. Buja LM; Ferrans VJ; Mayer RJ; Roberts WC; Henderson ES Cancer; 1973 Oct; 32(4):771-88. PubMed ID: 4270890 [No Abstract] [Full Text] [Related]
4. Daunorubicin (NSC-83142) in advanced childhood leukemia. Jaffe N; Traggis DG; Das L Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663 [No Abstract] [Full Text] [Related]
5. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia]. Marni E; Marchi A; Laini C; Zanol MG; Martini A; Livieri C; Genova R Minerva Pediatr; 1978 Feb; 30(4):333-8. PubMed ID: 273716 [No Abstract] [Full Text] [Related]
6. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience. Sallan SE; Clavell LA Semin Oncol; 1984 Dec; 11(4 Suppl 3):19-21. PubMed ID: 6594762 [No Abstract] [Full Text] [Related]
7. [57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P]. Bernard J; Jacquillat C; Boiron M; Weil M; Gémon MF; Izrael V; Schaison G; Delobel J Nouv Presse Med; 1972 Sep; 1(33):2149-52. PubMed ID: 4507740 [No Abstract] [Full Text] [Related]
8. [Rubidomycin in acute leukemia in children]. Armata J; Cyklis R; Garwicz S; Halikowski B; Wyszkowski J Pediatr Pol; 1969 Oct; 44(11):1405-12. PubMed ID: 5261217 [No Abstract] [Full Text] [Related]
9. [On the use of daunomycin in the therapy of acute leukemias]. Tura S; Baccarani M; Storti EF Minerva Med; 1969 Jul; 60(56):2810-20. PubMed ID: 5257049 [No Abstract] [Full Text] [Related]
10. The treatment of acute leukemia. Haskell CM; Cline MJ Ration Drug Ther; 1974 Oct; 8(10):1-7. PubMed ID: 4529560 [No Abstract] [Full Text] [Related]
11. [Trial of adriamycin in the treatment of acute leukemia]. Mathé G; Amiel JL; Hayat M; de Vassal F; Schwarzenberg L; Schneider M; Jasmin C; Rosenfeld C Presse Med (1893); 1970 Oct; 78(46):1997-9. PubMed ID: 5274058 [No Abstract] [Full Text] [Related]
12. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)]. Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847 [TBL] [Abstract][Full Text] [Related]
13. [Our recent therapeutic experiences in acute leukemia]. Quattrin N; Montuori R; Di Girolamo R; Cimino R Minerva Med; 1975 Jul; 66(51):2538-45. PubMed ID: 1057050 [No Abstract] [Full Text] [Related]
14. Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemia. Riccardi A; Invernizzi R; Girino M; Cassano E; Giordano M; Ucci G; Danova M; Montecucco C; Bobbio-Pallavicini E; Ascari E Haematologica; 1986; 71(2):129-33. PubMed ID: 3087833 [No Abstract] [Full Text] [Related]
15. [Combined treatment of acute leukemia with L-asparaginase and daunomycin]. Gerhartz H Haematol Lat; 1969; 12(3):821-7. PubMed ID: 5273188 [No Abstract] [Full Text] [Related]